The Role of Gamma-Delta T Lymphocytes in Inflammatory Muscle Disease

Author(s):  
Reinhard Hohlfeld ◽  
Andrew G. Engel
2019 ◽  
Vol 203 ◽  
pp. 88-96 ◽  
Author(s):  
Elizabeth S. Morrow ◽  
Antonia Roseweir ◽  
Joanne Edwards

AIDS ◽  
1994 ◽  
Vol 8 (3) ◽  
pp. 395 ◽  
Author(s):  
O. Perrella ◽  
A. Perrella ◽  
E. Soscia ◽  
A. Marinelli ◽  
V. Mininni ◽  
...  

Apmis ◽  
1990 ◽  
Vol 98 (7-12) ◽  
pp. 669-673 ◽  
Author(s):  
A.J. Gatrill ◽  
B. Schoel ◽  
H. Gulle ◽  
K. Pfeffer ◽  
H. Wagner ◽  
...  
Keyword(s):  

2019 ◽  
Vol 47 (5) ◽  
pp. 1393-1404 ◽  
Author(s):  
Thomas Brand

Abstract The Popeye domain-containing gene family encodes a novel class of cAMP effector proteins in striated muscle tissue. In this short review, we first introduce the protein family and discuss their structure and function with an emphasis on their role in cyclic AMP signalling. Another focus of this review is the recently discovered role of POPDC genes as striated muscle disease genes, which have been associated with cardiac arrhythmia and muscular dystrophy. The pathological phenotypes observed in patients will be compared with phenotypes present in null and knockin mutations in zebrafish and mouse. A number of protein–protein interaction partners have been discovered and the potential role of POPDC proteins to control the subcellular localization and function of these interacting proteins will be discussed. Finally, we outline several areas, where research is urgently needed.


2020 ◽  
Vol 21 (15) ◽  
pp. 1558-1565
Author(s):  
Matteo Santoni ◽  
Francesco Massari ◽  
Liang Cheng ◽  
Alessia Cimadamore ◽  
Marina Scarpelli ◽  
...  

The carcinogenesis of prostate cancer (PCa) results from a complex series of events. Chronic inflammation and infections are crucial in this context. Infiltrating M2 type macrophages, as well as neutrophils and T lymphocytes, contribute to PCa development, progression and response to therapy. The preliminary findings on the efficacy of immunotherapy in patients with PCa were not encouraging. However, a series of studies investigating anti-PD-L1 agents such as Atezolizumab, Avelumab and Durvalumab used alone or in combination with other immunotherapies, chemotherapy or locoregional approaches are in course in this tumor. In this review, we illustrate the role of immune cells and PD-L1 expression during PCa carcinogenesis and progression, with a focus on ongoing clinical trials on anti-PD-L1 agents in this context.


Sign in / Sign up

Export Citation Format

Share Document